Sophiris Bio, Inc. (SPHS): Price and Financial Metrics

Sophiris Bio, Inc. (SPHS): $0.00

0.00 (0.00%)

POWR Rating

Component Grades













Add SPHS to Watchlist
Sign Up

Industry: Biotech



in industry

SPHS Stock Price Chart Interactive Chart >

Price chart for SPHS

SPHS Price/Volume Stats

Current price $0.00 52-week high $0.05
Prev. close $0.00 52-week low $0.00
Day low $0.00 Volume 1,000
Day high $0.00 Avg. volume 0
50-day MA $0.01 Dividend yield N/A
200-day MA $0.02 Market Cap 3.56K

Sophiris Bio, Inc. (SPHS) Company Bio

Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of products for the treatment of urological diseases. The company was formerly known as Protox Therapeutics Inc. and changed its name to Sophiris Bio, Inc. in April 2012. The company was founded in 2002 and is based in La Jolla, California.

SPHS Latest News Stream

Event/Time News Detail
Loading, please wait...

SPHS Latest Social Stream

Loading social stream, please wait...

View Full SPHS Social Stream

Latest SPHS News From Around the Web

Below are the latest news stories about Sophiris Bio Inc that investors may wish to consider to help them evaluate SPHS as an investment opportunity.

The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J

The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 25.) Coherus Biosciences Inc (NASDAQ: CHRS ) The Medicines Company (NASDAQ: MDCO ) Down In The Dumps (Biotech stocks that hit 52-week lows Sept. 25.) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Advaxis, Inc. (NASDAQ: ADXS ) AnaptysBio Inc (NASDAQ: ANAB ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) AzurRx BioPharma Inc (NASDAQ: AZRX ) ( announced lackadaisical efficacy data for pancreatic insufficiency drug) BridgeBio Pharma Inc (NASDAQ: BBIO ) Calithera Biosciences Inc (NASDAQ: CALA ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Cellectis SA (NASDAQ: CLLS ) CytomX Therapeutics Inc (NASDAQ: CT...

Benzinga | September 26, 2019

Read More 'SPHS' Stories Here

SPHS Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year 0.00%
5-year 0.00%
2022 N/A
2021 0.00%
2020 -96.35%
2019 -55.42%
2018 -63.44%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6961 seconds.